Federal Supply Schedule 36F79724D0201

Award Date 9/1/24
Last Date to Order 8/31/29
Ultimate Awardee
Abbott Laboratories
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a multiple-award Federal Supply Schedule (FSS) contract by the U.S. Department of Veterans Affairs (VA) for Critical Analyzers, Laboratory (FSS-66-III). This contract has a ceiling value of $51.1 million and runs through April 14, 2026. Through this contract, Abbott Molecular provides a range of molecular diagnostics equipment, reagents, and testing services to support federal healthcare programs, particularly at VA...
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded multiple Federal Supply Schedule (FSS) contracts and Blanket Purchase Agreements (BPAs) by the Department of Veterans Affairs (VA) Veterans Health Administration to provide in vitro diagnostic products, reagents, and services. The contracts, valued up to $11.4 million, utilize the Invitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule and typically involve firm fixed price delivery orders for items such as...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 awarded a $10.8 million Blanket Purchase Agreement (BPA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of ALINITY M COVID-19 testing, HIV testing, and HPV testing supplies. The contract has a period of performance through September 21, 2026 and was not set aside for any specific business type. Under this BPA, the VA has awarded multiple firm fixed-price task orders to Abbott Molecular...
The Department of Veterans Affairs Veterans Integrated Service Network 2 (VA-VISN 2) awarded a Blanket Purchase Agreement (BPA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide nucleic acid and SARS testing services. The BPA, valued at up to $1.3 million, is based on Abbott Molecular's Federal Supply Schedule 66-III contract for Critical Analyzers, Laboratory products and services. Under this single-award IDV, Abbott Molecular will deliver real-time PCR testing...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Abbott Molecular Inc., a subsidiary of the global healthcare company Abbott Laboratories. The $12.5 million, 5-year BPA provides the VA with Alinity-M reagent kits, consumables, and related molecular diagnostics equipment and services. The contract does not utilize any set-aside designations, reflecting Abbott Molecular's status as a large, established medical technology provider. Under this BPA,...
The U.S. Department of Veterans Affairs (VA) has awarded a series of firm-fixed-price delivery orders under a single indefinite delivery contract (IDC) to Abbott Laboratories Inc., a global healthcare company, to provide a variety of COVID-19 testing products and services. These include SARS serology reagent test kits, SARS COV-2 testing services, and COVID-19 testing reagents and supplies. The delivery orders, valued at over $4.8 million in total, will support the VA's Veterans Integrated...
The Department of Veterans Affairs Strategic Acquisition Center Frederick awarded an Indefinite Delivery Contract to Abbott Molecular Inc. for COVID-19 testing reagents and materials. Under the contract, Abbott Molecular will provide Alinity M testing reagents and consumables to support the VA's coronavirus response efforts. Two firm fixed price delivery orders were issued against the contract. The first order, valued at $11 million, calls for Alinity M testing reagents to be delivered to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded Abbott Molecular Inc. two blanket purchase agreement call contracts to provide reagents and consumables from the Invitro Diagnostics, Reagents, Test General Services Administration Federal Supply Schedule 65-VII. The first BPA, awarded April 1, 2022 for $2,173,789.61, and the second awarded April 1, 2023 for $1,916,938.17, both have a period of performance through March 31, 2024....
The Department of Veterans Affairs (VA) has awarded a multiple-award Federal Supply Schedule (FSS) contract to Abbott Laboratories Inc., a subsidiary of Abbott Laboratories, for in-vitro diagnostics, reagents, and test kits. This $329.4 million contract, with a period of performance through February 2026, enables the VA to efficiently procure a range of medical devices, diagnostic equipment, and related consumables from Abbott to support veteran healthcare programs across the VA's regional...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The BPA, valued up to $3.2 million, is for the provision of Alinity M reagents and supplies, including COVID-19 testing reagents, to support the VA's medical diagnostic operations. The contract does not utilize any set-aside designations, as Abbott Molecular is a large business. The BPA...

The Federal Supply Schedule contract awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, provides a range of molecular diagnostic products and services to the U.S. Department of Veterans Affairs (VA). Under this multiple-award contract, Abbott Molecular will supply equipment, reagents, and testing capabilities related to sexually transmitted infections (STIs) and SARS-CoV-2 on the Alinity M platform. The $2,683,875.95 firm-fixed-price delivery order, awarded by the VA's Veterans Integrated Service Network 4, has a performance period through December 2029 and does not utilize any set-asides. As a leading provider of molecular diagnostics to federal agencies, Abbott Molecular has an extensive track record of supplying clinical testing platforms, consumables, and support services to the VA, Centers for Disease Control and Prevention, and Department of the Army. The company's diverse healthcare portfolio, which includes cardiovascular devices, nutritional products, and rapid COVID-19 tests, positions it as a significant supplier to federal healthcare programs, supporting patient care across multiple medical specialties.

Abbott Laboratories, the parent company of Abbott Molecular, holds several other Indefinite Delivery Vehicles with federal agencies, including a $150,000 single-award contract with the VA's Veterans Integrated Service Network 23 for histology reagents, a $107 million Indefinite Delivery Contract with the VA National Acquisition Center for dietary supplements and tube feeding products, and two Blanket Purchase Agreements with the Defense Health Agency valued at $249,999 and $250,000 for specialized food and nutrition supplements. These long-term partnerships demonstrate Abbott's commitment to providing critical medical products and nutritional supplies to support patient care in government healthcare facilities.

Generated 2/28/25, 9:49 AM